Top of page

Yuchen Han


Associate in our Corporate practice, currently assigned as a Legal Manager in Beijing.


Experience highlights

  • CARsgen Therapeutics $400 million Hong Kong IPO and global offering
  • JOINN Laboratories $844 million Hong Kong IPO and global offering
  • Antengene $357 million Hong Kong IPO and global offering
  • ADC Therapeutics $267 million U.S. IPO
  • Black Diamond Therapeutics $231.3 million U.S. IPO
  • China South City Holdings $250 million high-yield notes offering and concurrent cash tender offer
  • Magenta Therapeutics $69 million follow-on offering of common stock
  • Amerant Bancorp $60 million notes offering
  • LivaNova USA $287.5 million cash exchangeable senior notes offering
  • Ralph Lauren Corporation $1.25 billion notes offering
  • Lennox $600 Million senior notes offering
  • IDEX Corporation $500 million notes offering
  • Huntington Ingalls Industries $1 billion senior offering
  • GFL Environmental US IPO of $1.425 billion of subordinate voting shares and $775 million of tangible equity units
View more experience
J.D., Harvard Law School
  • cum laude
  • Submissions Committee, Harvard Journal of Law & Technology
Ph.D., Molecular Biology, Princeton University
M.A., Molecular Biology, Princeton University
B.Sc., Biology, Tsinghua University
Professional history
  • Davis Polk since 2019
Qualifications and admissions
  • State of New York
Back to top